The structure of disability due to malignant neoplasms of the reproductive system in terms of severity in the comparative aspect of the medical and social characteristics of women with disabilities

Abstract

BACKGROUND: Malignant neoplasms, while continuing to occupy the leading position among the causes of disability worldwide, are a medical and social problem in the Russian Federation. Malignant neoplasms of the reproductive system are the leading cause of morbidity among women. Persistent impairment of body functions caused by malignant neoplasms often leads to capacity limitations, necessitating social protection (disability). Additionally, the epidemiology of malignant neoplasms has reviled manifestation of regional features.

OBJECTIVE: The study aimed to analyze the indicators characterizing medical and social aspects of disability resulting from gynecological malignant neoplasms in different cohorts of women with disability in the Chechen Republic.

MATERIALS AND METHODS: Units of observation: contingents of people with disability due to cervical, uterine, and ovarian cancers among the adult population of the Chechen Republic. The analysis was carried out after the distribution of the participants into first, second, and third disability groups, considering severity of the disability. The study period: 2014–2020. Research methods: documentary, data copying, and statistical analysis.

RESULTS: For the structure of disability due to cervical and uterine cancer, there was an increase in the number of people with disability in the third group. In contrast, in the contingent of people with disability due to ovarian cancer, there was a negative trend in the increase in the number of people with disability in the second group (p < 0.0001). Elderly and middle age people with disability predominated in terms of physical labor. The main type of dysfunction observe was of the blood and immune system. Mobility impairments of the second and third degree were more common in the cohorts of patients with disability due to cervical cancer. The inability to conduct second degree self-care was common in ovarian cancer and of the third degree self-care in uterine cancer. The proportion of people with second degree of disability was practically the same in the cohorts of people with disability. In contrast, the extensive indicator of third degree disability was higher in the cohort of people with disability due to cervical cancer.

CONCLUSION: The results of the study made it possible to define medical and social characteristic of people with disability due to malignant neoplasms of the reproductive system in the Chechen Republic. This scientific and practical database of persistent health disorders of the female population with a distribution based on the severity of disabling oncopathology, when used within the framework of the regional aspect of health protection, will allow the development of rational and effective diagnosis, treatment, and rehabilitation measures, which will contribute to the medical and social prevention of disability.

Keywords

disability / cervical cancer / uterine cancer / ovarian cancer / severity / structure / functional impairment / capacity limitation

References

[1] Kaprin AD, Starinsky VV, Shakhzadova AO, editors. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Moscow: Herzen MNIOI; 2021. 252 p. (In Russ).

[2] Злокачественные новообразования в России в 2020 году (заболеваемость и смертность) / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Москва: МНИОИ им. П.А. Герцена, 2021. 252 с.

[3] Puzin SN, Shurgaya MA, Idrisova LS, Pogosyan GE, Suleymanov EA. Malignant neoplasms as a nosological cause of primary disability in the Russian Federation during the COVID-19 pandemic. Medical and social expert evaluation and rehabilitation. 2022;25(1):5–12. (In Russ). doi: 10.17816/MSER109319

[4] Пузин С.Н., Шургая М.А., Идрисова Л.С., Погосян Г.Э., Сулейманов Э.А. Злокачественные новообразования как нозологическая причина первичной инвалидности населения Российской Федерации в контексте пандемии COVID-19 // Медико-социальная экспертиза и реабилитация. 2022. Т. 25, № 1. C. 5–12. doi: 10.17816/MSER109319

[5] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinicians. 2021;71(3):209–49. doi: 10.3322/caac.2166

[6] Sung H., Ferlay J., Siegel R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA: Cancer J Clinicians. 2021. Vol. 71, № 3. P. 209–49. doi: 10.3322/caac.2166

[7] Dmitriev VN. Malignant neoplasms of the female reproductive system in the Belgorod region in comparison with all-Russian indicators: monograph. Belgorod: Epicenter; 2015. 212 p. (In Russ).

[8] Дмитриев В.Н. Злокачественные новообразования женской репродуктивной системы в Белгородской области в сопоставлении с общероссийскими показателями: монография. Белгород: Эпицентр, 2015. 212 с.

[9] Axel EM. Morbidity and mortality from malignant neoplasms of the female reproductive system in Russia. Oncogynecology. 2015;(1):8–9. (In Russ).

[10] Аксель Е.М. Заболеваемость и смертность от злокачественных новообразований женской репродуктивной системы в России // Онкогинекология. 2015. № 1. С. 8–9.

[11] Ashrafyan LA, Novikova EG, Tyulandina AS, Urmancheeva AF, et al. Cervical cancer. Clinical recommendations, 2020. Moscow: All-Russian National Union “Association of Oncologists of Russia”, Scientific Council of the Ministry of Health of the Russian Federation; 2019. 56 p. (In Russ).

[12] Ашрафян Л.А., Новикова Е.Г., Тюляндина А.С., Урманчеева А.Ф., и др. Рак шейки матки. Клинические рекомендации, 2020. Москва: Общероссийский национальный союз «Ассоциация онкологов России», научный совет Министерства здравоохранения Российской Федерации, 2019. 56 с.

[13] Nikoghosyan SO, Zagashtokov AZ, Levchenko NE, Thakokhov MM. Malignant ovarian tumors diagnostics difficulties tumors of female reproductive system. Tumors of the female reproductive system. 2018;14(2):82–89. (In Russ). doi: 10.17650/1994-4098-2018-14-2-82-89

[14] Никогосян С.О., Загаштоков А.З., Левченко Н.Е., Тхакохов М.М. Прогностические модели в диагностике рака яичников // Опухоли женской репродуктивной системы. 2018. Т. 14, № 2. С. 82–89. doi: 10.17650/1994-4098-2018-14-2-82-89

[15] Torre LA, Traber B, Desantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics. CA: Cancer J Clinicians. 2018;68(4):284–6. doi: 10.3322/caac.21456

[16] Torre L.A., Traber B., Desantis C.E., Miller K.D., Samimi G., Runowicz C.D., Gaudet M.M., Jemal A., Siegel R.L. Ovarian cancer statistics // CA: Cancer J Clinicians. 2018. Vol. 68, № 4. P. 284–6. doi: 10.3322/caac.21456

[17] World Health Organization (WHO). WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. WHO; 2018. Available from: who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/. Accessed: 15.10.2022.

[18] World Health Organization (WHO). WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. WHO; 2018. Режим доступа: who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/. Дата обращения: 15.01.2022.

[19] Colombo N, Creutzberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer. Diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26(1):2–30. doi: 10.1093/annonc/mdv484

[20] Colombo N., Creutzberg C., Amant F., et al. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer. Diagnosis, treatment and follow-up // Int J Gynecol Cancer. 2016. Vol. 26, № 1. P. 2–30. doi: 10.1093/annonc/mdv484

[21] Order of the Ministry of Labor and Social Protection of the Russian Federation of August 27, 2019 No. 585n “On the classifications and criteria used when implementing medico-social examination of citizens by federal state institutions of medico-social examination”. (In Russ). Available from: https://mintrud.gov.ru/. Accessed: 10.11.2022.

[22] Приказ Министерства труда и социальной защиты Российской Федерации от 27.08.2019 № 585н «О классификациях и критериях, используемых при осуществлении медико-социальной экспертизы граждан федеральными государственными учреждениями медико-социальной экспертизы». Режим доступа: https://mintrud.gov.ru/. Дата обращения: 10.11.2022.

[23] Proklova TN, Schepin VO, Chicherin LP, Telnova EA, Karpova OB, Mirgorodskaya OV. The persistent disability of population in the Russian Federation: analysis and assessment of regional characteristics. Problems of social hygiene, public health and history of medicine. 2020;28(4):555-559. (In Russ). doi: 10.32687/0869-866X-2020-28-4-555-559

[24] Проклова Т.Н., Щепин В.О., Чичерин Л.П., Тельнова Е.А., Карпова О.Б., Миргородская О.В. Стойкая нетрудоспособность населения Российской Федерации: анализ и оценка региональных особенностей // Проблемы социальной гигиены, здравоохранения и истории медицины. 2020. Т. 28, № 4. С. 555–559. doi: 10.32687/0869-866X-2020-28-4-555-559

[25] Idrisova LS, Suleymanov EA, Puzin SN, Shurgaya MA. Cervical cancer in a comparative aspect of its incidence and mortality in the female population in the Republic of Chechnya, North Caucasian federal district and Russia. Medical and social expert evaluation and rehabilitation. 2022;25(1):65–72. (In Russ). doi: 10.17816/MSER108609

[26] Идрисова Л.С., Сулейманов Э.А., Пузин С.Н., Шургая М.А. Рак шейки матки в сравнительном аспекте заболеваемости и смертности женского населения в Республике Чечня, Северо-Кавказском Федеральном округе и в России // Медико-социальная экспертиза и реабилитация. 2022. Т. 25, № 1. C. 65–72. doi: 10.17816/MSER108609

[27] Kaprin AD, Starinsky VV, Shakhzadova AO, editors. The state of oncological care for the population of Russia in 2021. Moscow: Herzen MNIOI; 2022. 239 p. (In Russ).

[28] Состояние онкологической помощи населению России в 2020 году / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Москва: МНИОИ им. П.А. Герцена, 2021. 239 с.

[29] National project “Health care”: federal project “Fight against oncological diseases”. Approved December 24, 2018 (implementation period 2019–2024). (In Russ). Available from: http://government.ru/. Accessed: 28.10.2022.

[30] Национальный проект «Здравоохранение»: федеральный проект «Борьба с онкологическими заболеваниями» (утв. 24 декабря 2018 г.; срок реализации 2019–2024 гг.). Режим доступа: http://government.ru/. Дата обращения: 28.01.2022.

RIGHTS & PERMISSIONS

Eco-Vector